Last reviewed · How we verify
NCT05714449
OCT Eccentric Fixation and Amblyopia in Children
NA trial testing eye patch in Amblyopia in 30 participants. Currently enrolling.
24 January 2025
Quick facts
| Lead sponsor | State University of New York College of Optometry |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 25 January 2023 |
| Primary completion | 24 January 2025 |
| Estimated completion | 24 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- eye patch
- After-image and MIT trainer
Conditions studied
- Amblyopia — all drugs for Amblyopia →
Sponsor
State University of New York College of Optometry
Who can join
Adults 4 to 16, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05714449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of eye patch
Trials testing the same drug.
- NCT03480789 — the Influence of Sleep Improvement Through Different Methods on Patients in ICU · NA · unknown
- NCT03255707 — A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia · NA · completed
Other recruiting trials for Amblyopia
Currently open trials in the same condition.
- NCT07323953 — Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children · NA · recruiting
- NCT07281742 — Amblyopia Treatment for Children Aged 8 to 12 Years · NA · recruiting
- NCT07417046 — Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopi · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
- NCT06380517 — Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age · Phase 3 · recruiting
Other State University of New York College of Optometry trials
Trials by the same sponsor.
- NCT05684224 — Assessing Dynamic Reading Behaviors Using Eye-Tracking Tobii Glasses · unknown
- NCT05505292 — Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers · Phase 4 · completed
- NCT05684250 — Effect of Biofeedback Training on Accommodation During Multifocal Lens Wear in Young Adults · NA · unknown
- NCT04448535 — Effects of Ginkgo (Gingko Biloba) on Retinal and Choroidal Ocular Tissue · NA · completed
- NCT04807361 — Assessment of Accommodation Behavior in Children Under Myopia Control Treatment (Pilot Study) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05714449 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by State University of New York College of Optometry
- Last refreshed: 23 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing